INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
MJ
Corporate insider

Mercier Johanna

Chief Commercial OfficerCIK 0001782135

EDGAR filingsOpen in network
Disclosed transactions10
Buys / sells0 / 3
Max Insider Score21
Connections with evidence2

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
7
MJ
Mercier JohannaChief Comm & Corp Aff Officer
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$469K
3,000 sh
Oct 15, 2026Oct 16, 2026
traded Oct 15, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    NEUROCRINE BIOSCIENCES INCDirector · May 29, 2026
  • Insider ofevidence
    GILEAD SCIENCES, INC.Chief Commercial Officer · Dec 11, 2025
9
MJ
Mercier JohannaChief Comm & Corp Aff Officer
GILDGILEAD SCIENCES, INC.
Option exercise
M
—
2,797 sh
Sep 10, 2026
Sep 11, 2026
traded Sep 10, 2026
+1d
SEC FORM 4

Evidence

8
MJ
Mercier JohannaChief Comm & Corp Aff Officer
GILDGILEAD SCIENCES, INC.
Tax withholding
F$195K
1,347 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

5
MJ
Mercier JohannaChief Comm & Corp Aff Officer
GILDGILEAD SCIENCES, INC.
Option exercise
M—
2,797 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

9
MJ
Mercier JohannaDirector
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
2,567 sh
May 27, 2026May 29, 2026
traded May 27, 2026
+2dSEC FORM 4

Evidence

12
MJ
Mercier JohannaChief Comm & Corp Aff Officer
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$423K
3,000 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC FORM 4

Evidence

21
MJ
Mercier JohannaChief Commercial Officer
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$373K
3,000 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC FORM 4

Evidence

13
MJ
Mercier JohannaChief Commercial Officer
GILDGILEAD SCIENCES, INC.
Option exercise
M—
3,842 sh
Dec 10, 2025Dec 11, 2025
traded Dec 10, 2025
+1dSEC FORM 4

Evidence

9
MJ
Mercier JohannaChief Commercial Officer
GILDGILEAD SCIENCES, INC.
Option exercise
M—
3,842 sh
Dec 10, 2025Dec 11, 2025
traded Dec 10, 2025
+1dSEC FORM 4

Evidence

12
MJ
Mercier JohannaChief Commercial Officer
GILDGILEAD SCIENCES, INC.
Tax withholding
F$220K
1,814 sh
Dec 10, 2025Dec 11, 2025
traded Dec 10, 2025
+1dSEC FORM 4

Evidence